20-F: Ehave, Inc. Reports Significant Operating Losses and Going Concern Uncertainty in 2022 Annual Report

Ehave, Inc.'s 2022 annual report reveals substantial operating losses and raises concerns about the company's ability to continue as a going concern due to its accumulated deficit and need for additional capital.

Summary

• Ehave, Inc. reported a net loss of $5,091,470 for the fiscal year ended December 31, 2022, and an accumulated deficit of $34,167,210.
• The company's independent auditors have expressed concern about its ability to continue as a going concern without significant additional capital.
• Ehave is focused on developing its Ehave Dashboard, MegaTeam, and Ninja Reflex products, and KetaDash platform.
• The company intends to fund its operations through equity offerings, debt financings, and strategic partnerships.
• Ehave's common shares are quoted on the Pink Open Market under the symbol EHVVF.
• The company identified a material weakness in its internal control over financial reporting related to a lack of independent oversight.
• Ehave is subject to various healthcare laws and regulations, including HIPAA and the Anti-Kickback Statute.
• The company's future success depends on its ability to develop and commercialize new products, raise capital, and compete in the market.
• Ehave's business strategy involves developing the Ehave Dashboard, expanding MegaTeam and Ninja Reflex, forming strategic alliances, and developing relationships with pharmaceutical and insurance companies.
• The company's marketing channels consist of direct sales and leveraging partners for market outreach.

Sentiment

Score: 3

Explanation: The document presents a concerning financial situation with significant losses, auditor concerns about going concern, and a material weakness in internal controls. While there are some positive aspects, the overall tone is negative from an investment perspective.

Positives

• General and administrative expenses decreased by 64% to $3,303,581 for the year ended December 31, 2022, compared to $9,088,841 for the year ended December 31, 2021.
• The company is focused on developing its Ehave Dashboard, MegaTeam, and Ninja Reflex products, and KetaDash platform, which could lead to future revenue generation.
• The company is exploring various financing options, including equity funding and strategic collaboration, to address its going concern uncertainty.

Negatives

• Ehave, Inc. reported a net loss of $5,091,470 for the fiscal year ended December 31, 2022, and an accumulated deficit of $34,167,210.
• The company's independent auditors have expressed concern about its ability to continue as a going concern without significant additional capital.
• The company's total cash balance as of December 31, 2022, was $1,356,274.
• The company's common shares are quoted on the Pink Open Market, which is a limited market with greater risk to investors.
• The company identified a material weakness in its internal control over financial reporting related to a lack of independent oversight.
• The company is in default on its convertible notes as of December 31, 2022.

Risks

• The company's limited operating history makes evaluating its business and future prospects difficult.
• The company has a history of operating losses and expects to continue incurring losses for the foreseeable future.
• If the company is unable to obtain additional funding, its business operations will be harmed.
• The company's products may not be successful in gaining market acceptance.
• The company may not be able to keep up with rapid technological changes in its field.
• The company faces competition from better-established companies with greater resources.
• The company could infringe on the intellectual property rights of others.
• The market for the company's products is immature and volatile.
• The company may be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations.
• The company may not be in compliance with rules and regulations of the U.S. Food and Drug Administration (the FDA) should they become applicable to any products we develop in the future.

Future Outlook

The company anticipates continuing to incur losses and negative cash flows from operations and is exploring various financing options, including equity offerings, debt financings, and strategic collaborations.

Industry Context

The company operates in the mental healthcare and digital therapeutics market, which is a growing but competitive industry. The company faces competition from established players and must navigate regulatory requirements and market acceptance challenges.

Comparison to Industry Standards

• Akili Interactive, Attentiv, Myndlift and C8Sciences are competitors in the MegaTeam and Ninja Reflex game applications market.
• Epic, Allscripts and GE Healthcare are leaders in the EHR market and are better funded than Ehave's offering.
• Novamind and Field Trip Health are companies offering Ketamine infusion therapy for the treatment of mental illness.

Related Party Transactions

• The company has entered into consulting contracts with each of its officers.
• The company entered into an Executive Consulting Agreement with Benjamin Kaplan to serve as the Company's CEO.
• The company entered into a consulting agreement with the Company's CFO, James Cardwell.

Stakeholder Impact

• Shareholders may experience dilution if the company raises additional capital through equity offerings.
• Employees may be affected by potential cost-cutting measures if the company is unable to secure additional funding.
• Customers may be impacted by the company's ability to continue developing and supporting its products.
• Creditors may be at risk if the company is unable to meet its debt obligations.

Next Steps

• The company plans to continue the commercialization of its products.
• The company plans to raise capital through a combination of equity offerings, debt financings, other third-party funding and other collaborations and strategic partnerships.
• The company intends to take guidance into consideration as it works to resolve the material weakness in internal controls.

Key Dates

Keywords

Ehave, financial results, going concern, net loss, operating losses, accumulated deficit, convertible notes, KetaDash, MegaTeam, Ninja Reflex, mental health, digital therapeutics, financial statements, risk factors, internal control, auditor opinion